Type 1 Diabetes - Farmington Hills MI (Metro Detroit)

Summary:

Are there other options for managing low blood sugar from T1DM?

If you have asked yourself this question, consider enrolling in the CATT1 study, which is researching a study drug that may help.

The CATT1 study will look at whether the study drug, cadisegliatin (also called TTP399), can reduce the frequency of low blood sugar (hypoglycemia) in adults with type 1 diabetes mellitus (T1DM). The study drug is a tablet taken by mouth. It is designed to stimulate the liver and improve the liver’s ability to store sugar from food, which may reduce episodes of high or low blood sugar.

The study drug is a tablet taken by mouth. It is designed to stimulate the liver and improve the liver’s ability to store sugar from food, which may reduce episodes of high or low blood sugar.

Qualified Participants Must:

• Be an adult with Type 1 Diabetes

Qualified Participants May Receive:

Study participants receive:

• Possible access to a study drug
• Some participants will receive placebo, which has no active ingredients
• Study support and monitoring by a healthcare team
• Education about diabetes and hypoglycemia
• Compensation for your time and participation
• The opportunity to help advance type 1 diabetes mellitus research

Other study requirements for participation apply.